{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:34:09Z","timestamp":1790217249210,"version":"4.1.0"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.sleep.2023.11.033","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T18:38:43Z","timestamp":1701283123000},"page":"198-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates"],"prefix":"10.1016","volume":"113","author":[{"given":"Michele","family":"Fornaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6275-0657","authenticated-orcid":false,"given":"Claudio","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Rossano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"de Bartolomeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2023.11.033_bib1","series-title":"Principles and practice of sleep medicine","author":"Carskadon","year":"2011"},{"key":"10.1016\/j.sleep.2023.11.033_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neubiorev.2014.08.001","article-title":"The energy allocation function of sleep: a unifying theory of sleep, torpor, and continuous wakefulness","volume":"47","author":"Schmidt","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"10.1016\/j.sleep.2023.11.033_bib3","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1371\/journal.pbio.0060216","article-title":"Is sleep essential?","volume":"6","author":"Cirelli","year":"2008","journal-title":"PLoS Biol"},{"key":"10.1016\/j.sleep.2023.11.033_bib4","article-title":"We spend about one-third of our life either sleeping or attempting to do so","volume":"98","author":"Aminoff","year":"2011","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0301-0082(94)00057-O","article-title":"Restoration of brain energy metabolism as the function of sleep","volume":"45","author":"Benington","year":"1995","journal-title":"Prog Neurobiol"},{"issue":"1\u20132","key":"10.1016\/j.sleep.2023.11.033_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0166-4328(95)00014-K","article-title":"Sleep as neuronal detoxification and restitution","volume":"69","author":"Inou\u00e9","year":"1995","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib7","doi-asserted-by":"crossref","first-page":"R374","DOI":"10.1152\/ajpregu.00565.2004","article-title":"Antioxidant defense responses to sleep loss and sleep recovery","volume":"288","author":"Everson","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6156","key":"10.1016\/j.sleep.2023.11.033_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-8993(00)03008-0","article-title":"Gene expression in the brain across the sleep-waking cycle","volume":"885","author":"Cirelli","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.sleep.2023.11.033_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1749-6632.2009.04416.x","article-title":"The role of sleep in cognition and emotion","volume":"1156","author":"Walker","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.sleep.2023.11.033_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/NSS.S134864","article-title":"Short- and long-term health consequences of sleep disruption","volume":"9","author":"Medic","year":"2017","journal-title":"Nat Sci Sleep"},{"issue":"11","key":"10.1016\/j.sleep.2023.11.033_bib12","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5664\/jcsm.6288","article-title":"Consensus statement of the American academy of sleep medicine on the recommended amount of sleep for healthy children: methodology and discussion","volume":"12","author":"Paruthi","year":"2016","journal-title":"J Clin Sleep Med"},{"issue":"4 Suppl","key":"10.1016\/j.sleep.2023.11.033_bib13","first-page":"S91","article-title":"Economic burden and managed care considerations for the treatment of insomnia","volume":"26","author":"Taddei-Allen","year":"2020","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.sleep.2023.11.033_bib14","volume":"1","author":"Association","year":"2022"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsmc.2022.03.003","article-title":"Epidemiology of insomnia: prevalence, course, risk factors, and public health burden","volume":"17","author":"Morin","year":"2022","journal-title":"Sleep Med Clin"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/smrv.2000.0146","article-title":"Secondary insomnia: diagnostic challenges and intervention opportunities","volume":"5","author":"McCrae","year":"2001","journal-title":"Sleep Med Rev"},{"issue":"11","key":"10.1016\/j.sleep.2023.11.033_bib17","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.1989.03430110069030","article-title":"Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?","volume":"262","author":"Ford","year":"1989","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ncl.2012.08.018","article-title":"Psychiatric disorders and sleep","volume":"30","author":"Krystal","year":"2012","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib19","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/jcmm.14170","article-title":"Depression in sleep disturbance: a review on a bidirectional relationship, mechanisms and treatment","volume":"23","author":"Fang","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy215","article-title":"Insomnia and suicidal ideation in nonaffective psychosis","volume":"42","author":"Miller","year":"2019","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0973-1229.104497","article-title":"Polypharmacy in psychiatry: a review","volume":"11","author":"Kukreja","year":"2013","journal-title":"Mens Sana Monogr"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0278-5846(01)00306-2","article-title":"The use of drug monotherapy in psychiatric inpatient treatment","volume":"26","author":"Rittmannsberger","year":"2002","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatr"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00406-021-01358-5","article-title":"Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia","volume":"272","author":"Stassen","year":"2022","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"issue":"9","key":"10.1016\/j.sleep.2023.11.033_bib24","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/pds.5310","article-title":"Polypharmacy and the risk of drug\u2013drug interactions and potentially inappropriate medications in hospital psychiatry","volume":"30","author":"Wolff","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National trends in psychotropic medication polypharmacy in office-based psychiatry","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch Gen Psychiatr"},{"issue":"10","key":"10.1016\/j.sleep.2023.11.033_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad177","article-title":"Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis","volume":"46","author":"Zhou","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.033_bib27","doi-asserted-by":"crossref","unstructured":"Miller Brian J, McCall William V. Insomnia and suicide as reported adverse effects of second-generation antipsychotics and mood stabilizers. J Clin Sleep Med.18(2):517-522.","DOI":"10.5664\/jcsm.9646"},{"issue":"8","key":"10.1016\/j.sleep.2023.11.033_bib28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ps.52.8.1033","article-title":"Psychopharmacology: rational and irrational polypharmacy","volume":"52","author":"Kingsbury","year":"2001","journal-title":"Psychiatr Serv"},{"issue":"39","key":"10.1016\/j.sleep.2023.11.033_bib29","doi-asserted-by":"crossref","first-page":"9574","DOI":"10.1523\/JNEUROSCI.0580-17.2017","article-title":"Hypothalamic tuberomammillary nucleus neurons: electrophysiological diversity and essential role in arousal stability","volume":"37","author":"Fujita","year":"2017","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","article-title":"Histamine in the regulation of wakefulness","volume":"15","author":"Thakkar","year":"2011","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.033_bib31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/B978-0-444-52007-4.00006-0","article-title":"Hypothalamus, hypocretins\/orexin, and vigilance control","volume":"99","author":"Nishino","year":"2011","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0031-1299728","article-title":"\u03b1-Adrenergic receptor function, arousal and sleep: mechanisms and therapeutic implications","volume":"45","author":"Broese","year":"2012","journal-title":"Pharmacopsychiatry"},{"issue":"7063","key":"10.1016\/j.sleep.2023.11.033_bib33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.sleep.2023.11.033_bib34","series-title":"Serotonin and sleep: molecular, functional and clinical aspects","author":"Monti","year":"2008"},{"key":"10.1016\/j.sleep.2023.11.033_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.euroneuro.2023.07.008","article-title":"The efficacy, safety, and adverse events of azapirones in anxiety disorders: a systematic review and meta-analysis of randomized controlled trials","volume":"76","author":"Rossano","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2010.11.003","article-title":"Serotonin control of sleep-wake behavior","volume":"15","author":"Monti","year":"2011","journal-title":"Sleep Med Rev"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0006-8993(99)02237-4","article-title":"Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration","volume":"853","author":"Ikemoto","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.sleep.2023.11.033_bib38","series-title":"Serotonin and sleep: molecular, functional and clinical aspects","first-page":"387","article-title":"Effect of 5-HT2A\/2B\/2C receptor agonists and antagonists on sleep and waking in laboratory animals and humans","author":"Kitka","year":"2008"},{"key":"10.1016\/j.sleep.2023.11.033_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnbeh.2017.00010","article-title":"Basal forebrain cholinergic system and orexin neurons: effects on attention","volume":"11","author":"Villano","year":"2017","journal-title":"Front Behav Neurosci"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.smrv.2008.12.003","article-title":"Effects of nicotine on sleep during consumption, withdrawal and replacement therapy","volume":"13","author":"Jaehne","year":"2009","journal-title":"Sleep Med Rev"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0024-3205(93)90300-R","article-title":"Immunological localization of m1\u2013m5 muscarinic acetylcholine receptors in peripheral tissues and brain","volume":"52","author":"Levey","year":"1993","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002130050482","article-title":"Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine","volume":"135","author":"Curran","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3565(25)25749-4","article-title":"The effects of atropine on the electroencephalogram and behavior in man","volume":"128","author":"Ostfeld","year":"1960","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"7","key":"10.1016\/j.sleep.2023.11.033_bib44","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/cne.24158","article-title":"Descending projections from the basal forebrain to the orexin neurons in mice","volume":"525","author":"Agostinelli","year":"2017","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41386-019-0444-2","article-title":"Arousal and sleep circuits","volume":"45","author":"Jones","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1471-4159.2011.07350.x","article-title":"Sleep duration varies as a function of glutamate and GABA in rat pontine reticular formation","volume":"118","author":"Watson","year":"2011","journal-title":"J Neurochem"},{"issue":"15","key":"10.1016\/j.sleep.2023.11.033_bib47","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00018-011-0631-8","article-title":"The waking brain: an update","volume":"68","author":"Lin","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.sleep.2023.11.033_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1152\/jn.1951.14.2.133","article-title":"Organization of the diffuse thalamic projection system","volume":"14","author":"Starzl","year":"1951","journal-title":"J Neurophysiol"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1523\/JNEUROSCI.2244-05.2006","article-title":"Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter","volume":"26","author":"Lu","year":"2006","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/jpet.103.053918","article-title":"Wake-promoting actions of dopamine D1 and D2 receptor stimulation","volume":"307","author":"Isaac","year":"2003","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib51","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s00429-017-1365-7","article-title":"Activation of ventral tegmental area dopamine neurons produces wakefulness through dopamine D(2)-like receptors in mice","volume":"222","author":"Oishi","year":"2017","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.sleep.2023.11.033_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1101\/sqb.2007.72.043","article-title":"Entrainment of the human circadian clock","volume":"72","author":"Roenneberg","year":"2007","journal-title":"Cold Spring Harbor Symp Quant Biol"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cpr.2006.07.001","article-title":"The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation","volume":"26","author":"Grandin","year":"2006","journal-title":"Clin Psychol Rev"},{"issue":"11","key":"10.1016\/j.sleep.2023.11.033_bib54","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/sleep\/30.11.1460","article-title":"Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review","volume":"30","author":"Sack","year":"2007","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib55","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuron.2017.01.014","article-title":"Neural circuitry of wakefulness and sleep","volume":"93","author":"Scammell","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.sleep.2023.11.033_bib56","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.conb.2017.03.021","article-title":"Wake\u2013sleep circuitry: an overview","volume":"44","author":"Saper","year":"2017","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jsmc.2018.03.002","article-title":"Sleep-wake neurochemistry","volume":"13","author":"Holst","year":"2018","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.sleep.2023.11.033_bib58","series-title":"Basic neurochemistry","first-page":"982","article-title":"Chapter 57 - the neurochemistry of sleep and wakefulness","author":"Baghdoyan","year":"2012"},{"issue":"8","key":"10.1016\/j.sleep.2023.11.033_bib59","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1210\/jcem.86.8.7778","article-title":"Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.sleep.2023.11.033_bib60","series-title":"Principles and practice of sleep medicine","article-title":"Chapter 82 - etiology and pathophysiology of insomnia","author":"Perlis","year":"2017"},{"issue":"3\u20134","key":"10.1016\/j.sleep.2023.11.033_bib61","first-page":"28","article-title":"Comorbid insomnia and psychiatric disorders: an update","volume":"15","author":"Khurshid","year":"2018","journal-title":"Innov Clin Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.sleep.2023.11.033_bib63","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"Suppl 16","key":"10.1016\/j.sleep.2023.11.033_bib64","first-page":"27","article-title":"Daytime sleepiness and insomnia as correlates of depression","volume":"65","author":"Fava","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s43045-021-00124-6","article-title":"Alertness in patients with treatment-resistant depression: interface between sleep medicine and psychiatry\u2014review article","volume":"28","author":"Kolar","year":"2021","journal-title":"Middle East Current Psychiatry"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1192\/bjp.bp.117.202259","article-title":"Sleep loss as a trigger of mood episodes in bipolar disorder: individual differences based on diagnostic subtype and gender","volume":"211","author":"Lewis","year":"2017","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib67","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1176\/appi.ajp.162.1.50","article-title":"Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems","volume":"162","author":"Harvey","year":"2005","journal-title":"Am J Psychiatr"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.31887\/DCNS.2003.5.3\/lstaner","article-title":"Sleep and anxiety disorders","volume":"5","author":"Staner","year":"2003","journal-title":"Dialogues Clin Neurosci"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.smrv.2012.12.002","article-title":"Sleep and obsessive-compulsive disorder (OCD)","volume":"17","author":"Paterson","year":"2013","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.033_bib70","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fpsyt.2020.00486","article-title":"Sleep problems and social impairment in psychosis: a transdiagnostic study examining multiple social domains","volume":"11","author":"Blanchard","year":"2020","journal-title":"Front Psychiatr"},{"issue":"12","key":"10.1016\/j.sleep.2023.11.033_bib71","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.5665\/sleep.5232","article-title":"The association between sleep problems and psychotic symptoms in the general population: a global perspective","volume":"38","author":"Koyanagi","year":"2015","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib72","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1192\/bjp.182.5.373","article-title":"Pathways to emotional dysfunction in first-episode psychosis","volume":"182","author":"Birchwood","year":"2003","journal-title":"Br J Psychiatr"},{"key":"10.1016\/j.sleep.2023.11.033_bib73","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fnins.2020.00636","article-title":"Disrupted sleep and circadian rhythms in schizophrenia and their interaction with dopamine signaling","volume":"14","author":"Ashton","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.sleep.2023.11.033_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104850","article-title":"Insomnia and post-traumatic stress disorder: a meta-analysis on interrelated association (n = 57,618) and prevalence (n = 573,665)","volume":"141","author":"Ahmadi","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/204946370800200102","article-title":"Insomnia Co-occurring with chronic pain: clinical features, interaction, assessments and possible interventions","volume":"2","author":"Tang","year":"2008","journal-title":"Rev Pain"},{"issue":"7","key":"10.1016\/j.sleep.2023.11.033_bib76","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/art.23828","article-title":"Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression","volume":"59","author":"Bigatti","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5056\/jnm.2010.16.1.22","article-title":"Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications","volume":"16","author":"Jung","year":"2010","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.sleep.2023.11.033_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.725829","article-title":"Thyroid dysfunction and sleep disorders","volume":"12","author":"Green","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.sleep.2023.11.033_bib79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/JAA.S345086","article-title":"Prevalence of insomnia among patients with bronchial asthma","volume":"15","author":"Al-Harbi","year":"2022","journal-title":"J Asthma Allergy"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.juro.2013.07.011","article-title":"Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study","volume":"191","author":"Araujo","year":"2014","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/CPJ.0b013e3182a78edf","article-title":"Approach to insomnia in patients with dementia","volume":"4","author":"Molano","year":"2014","journal-title":"Neurol Clin Pract"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib82","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1191\/135248506ms1320oa","article-title":"Sleep and fatigue in multiple sclerosis","volume":"12","author":"Stanton","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.sleep.2023.11.033_bib83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fneur.2017.00042","article-title":"The treatment of sleep disorders in Parkinson's disease: from research to clinical practice","volume":"8","author":"Loddo","year":"2017","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib84","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/nedt.2006.2.4.513","article-title":"Effects of restless legs syndrome (RLS) on sleep","volume":"2","author":"Bogan","year":"2006","journal-title":"Neuropsychiatric Dis Treat"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18063209","article-title":"Insomnia associated with tinnitus and gender differences","volume":"18","author":"Richter","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31887\/DCNS.2005.7.4\/vabad","article-title":"Sleep and psychiatry","volume":"7","author":"Abad","year":"2005","journal-title":"Dialogues Clin Neurosc"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib87","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1521-0391.2010.00035.x","article-title":"Prevalence and correlates of withdrawal-related insomnia among adults with alcohol dependence: results from a national survey","volume":"19","author":"Brower","year":"2010","journal-title":"Am J Addict"},{"issue":"11","key":"10.1016\/j.sleep.2023.11.033_bib88","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","article-title":"The benzodiazepine withdrawal syndrome","volume":"89","author":"P\u00e9tursson","year":"1994","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0975-3583.85261","article-title":"Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients","volume":"2","author":"Fares","year":"2011","journal-title":"J Cardiovasc Dis Res"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib90","first-page":"260","article-title":"Steroid-induced sleep disturbance and delirium: a focused review for critically ill patients","volume":"37","author":"Cole","year":"2020","journal-title":"Fed Pract"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4065\/81.1.53","article-title":"Angiotensin-converting enzyme inhibitors and obstructive sleep apnea","volume":"81","author":"Cicolin","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib92","first-page":"915","article-title":"Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials","volume":"11","author":"Broncel","year":"2015","journal-title":"Arch Med Sci"},{"issue":"9","key":"10.1016\/j.sleep.2023.11.033_bib93","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatr Rep"},{"issue":"sup1","key":"10.1016\/j.sleep.2023.11.033_bib94","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1080\/15622975.2018.1468030","article-title":"Anxiolytics targeting GABA(A) receptors: insights on etifoxine","volume":"19","author":"Poisbeau","year":"2018","journal-title":"World J Biol Psychiatr"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib95","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1871527320666210618103344","article-title":"Benzodiazepines and sleep architecture: a systematic review","volume":"22","author":"de Mendon\u00e7a","year":"2023","journal-title":"CNS Neurol Disord: Drug Targets"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib96","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib97","doi-asserted-by":"crossref","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","article-title":"Benzodiazepine use, misuse, and abuse: a review","volume":"6","author":"Schmitz","year":"2016","journal-title":"Ment Health Clin"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib98","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/ADM.0000000000000291","article-title":"\"Should patients with substance use disorders Be prescribed benzodiazepines?\" No","volume":"11","author":"DuPont","year":"2017","journal-title":"J Addiction Med"},{"key":"10.1016\/j.sleep.2023.11.033_bib99","series-title":"FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use","year":"2016"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/appi.ps.55.3.233","article-title":"Practical geriatrics: use of benzodiazepines among elderly patients","volume":"55","author":"Olivera","year":"2004","journal-title":"Psychiatr Serv"},{"issue":"10","key":"10.1016\/j.sleep.2023.11.033_bib102","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","article-title":"Benzodiazepine misuse in the elderly: risk factors, consequences, and management","volume":"18","author":"Airagnes","year":"2016","journal-title":"Curr Psychiatr Rep"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib103","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1183\/09031936.00008014","article-title":"Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD","volume":"44","author":"Vozoris","year":"2014","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.sleep.2023.11.033_bib104","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1542\/pir.18-8-260","volume":"18","author":"Coupey","year":"1997","journal-title":"Barbiturates. Pediatr Rev."},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","article-title":"The clinical and forensic toxicology of Z-drugs","volume":"9","author":"Gunja","year":"2013","journal-title":"J Med Toxicol"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib106","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13181-013-0294-y","article-title":"In the Zzz zone: the effects of Z-drugs on human performance and driving","volume":"9","author":"Gunja","year":"2013","journal-title":"J Med Toxicol"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib107","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R"},{"key":"10.1016\/j.sleep.2023.11.033_bib108","series-title":"Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)","year":"2013"},{"key":"10.1016\/j.sleep.2023.11.033_bib109","series-title":"FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines: FDA drug safety communication","year":"2019"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines agency database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2023.11.033_bib111","series-title":"Physiology of the pineal gland and melatonin","author":"Arendt","year":"2000"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib112","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-079X.1995.tb00180.x","article-title":"Permeability of pure lipid bilayers to melatonin","volume":"19","author":"Costa","year":"1995","journal-title":"J Pineal Res"},{"issue":"7538","key":"10.1016\/j.sleep.2023.11.033_bib113","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.38731.532766.F6","article-title":"Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis","volume":"332","author":"Buscemi","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2023.11.033_bib114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1740-3391-6-10","article-title":"Efficacy and hypnotic effects of melatonin in shift-work nurses: double-blind, placebo-controlled crossover trial","volume":"6","author":"Sadeghniiat-Haghighi","year":"2008","journal-title":"J Circadian Rhythms"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib115","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/14656566.2012.667076","article-title":"Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia","volume":"13","author":"Lemoine","year":"2012","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.sleep.2023.11.033_bib117","series-title":"Slenyto summary of product characteristics (SmPC)","year":"2018"},{"key":"10.1016\/j.sleep.2023.11.033_bib118","series-title":"Summary safety review - MELATONIN (N-acetyl-5-methoxytryptamine) - review of the safety of melatonin in children and adolescents","author":"Canada","year":"2015"},{"key":"10.1016\/j.sleep.2023.11.033_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101080","article-title":"Efficacy of pharmacologic treatment in tinnitus patients without specific or treatable origin: a network meta-analysis of randomised controlled trials","volume":"39","author":"Chen","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib120","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3390\/ijms16011111","article-title":"Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression","volume":"16","author":"De Berardis","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib121","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1017\/S1461145707007754","article-title":"Major depressive disorder, sleep EEG and agomelatine: an open-label study","volume":"10","author":"Salva","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2023.11.033_bib122","series-title":"Ramelteon highlights of prescribing information","author":"Pharmaceuticals","year":"2021"},{"issue":"8","key":"10.1016\/j.sleep.2023.11.033_bib123","first-page":"1437","article-title":"Ramelteon (rozerem) for insomnia","volume":"73","author":"Ward","year":"2006","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib124","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1755-5949.2008.00066.x","article-title":"Pharmacology of ramelteon, a selective MT1\/MT2 receptor agonist: a novel therapeutic drug for sleep disorders","volume":"15","author":"Miyamoto","year":"2009","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"10.1016\/j.sleep.2023.11.033_bib125","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.5665\/SLEEP.1272","article-title":"Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects","volume":"34","author":"Mets","year":"2011","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib126","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ncl.2019.03.002","article-title":"Non-24-hour sleep-wake rhythm disorder","volume":"37","author":"Abbott","year":"2019","journal-title":"Neurol Clin"},{"key":"10.1016\/j.sleep.2023.11.033_bib127","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","article-title":"Orexin receptors: pharmacology and therapeutic opportunities","volume":"51","author":"Scammell","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.sleep.2023.11.033_bib128","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2020.05.025","article-title":"Lemborexant vs suvorexant for insomnia: a systematic review and network meta-analysis","volume":"128","author":"Kishi","year":"2020","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.sleep.2023.11.033_bib129","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.5665\/sleep.5168","article-title":"On-the-Road driving performance the morning after bedtime use of suvorexant 20 and 40 mg: a study in non-elderly healthy volunteers","volume":"38","author":"Vermeeren","year":"2015","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00325481.2020.1823724","article-title":"Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials","volume":"133","author":"Moline","year":"2021","journal-title":"Postgrad Med"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40265-022-01699-y","article-title":"Daridorexant: first approval","volume":"82","author":"Markham","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.sleep.2023.11.033_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2020.101332","article-title":"Effects of orexin receptor antagonism on human sleep architecture: a systematic review","volume":"53","author":"Clark","year":"2020","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.033_bib133","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.sleep.2015.10.007","article-title":"Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data","volume":"19","author":"Snyder","year":"2016","journal-title":"Sleep Med"},{"issue":"Supplement_1","key":"10.1016\/j.sleep.2023.11.033_bib134","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz067.368","article-title":"0369 effect of lemborexant on sleep architecture in older adults with insomnia disorder","volume":"42","author":"Moline","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.033_bib135","series-title":"Sleep disorder (Sedative-Hypnotic) drug information","year":"2019"},{"key":"10.1016\/j.sleep.2023.11.033_bib136","first-page":"401","article-title":"Doxylamine succinate\u2013pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an overview","volume":"6","author":"Nuangchamnong","year":"2014","journal-title":"Int J Wom Health"},{"key":"10.1016\/j.sleep.2023.11.033_bib137","series-title":"FDA warns about serious problems with high doses of the allergy medicine diphenhydramine (Benadryl)","year":"2022"},{"key":"10.1016\/j.sleep.2023.11.033_bib138","series-title":"VISTARIL\u00ae (hydroxyzine pamoate) capsules and oral suspension","author":"Labs","year":"2014"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib139","article-title":"Over-the-Counter agents for the treatment of occasional disturbed sleep or transient insomnia: a systematic review of efficacy and safety","volume":"17","author":"Culpepper","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"issue":"9","key":"10.1016\/j.sleep.2023.11.033_bib140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatr Rep"},{"key":"10.1016\/j.sleep.2023.11.033_bib141","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/NSS.S6849","article-title":"Role of 5-HT2A receptor antagonists in the treatment of insomnia","volume":"2","author":"Vanover","year":"2010","journal-title":"Nat Sci Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib142","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/ijms22031333","article-title":"Association of sleep architecture and physiology with depressive disorder and antidepressants treatment","volume":"22","author":"Hutka","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib143","doi-asserted-by":"crossref","DOI":"10.2196\/12613","article-title":"Relationship between sleep quality and mood: ecological momentary assessment study","volume":"6","author":"Triantafillou","year":"2019","journal-title":"JMIR Ment Health"},{"key":"10.1016\/j.sleep.2023.11.033_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.561564","article-title":"Insomnia is associated with frequency of suicidal ideation independent of depression: a replication and extension of findings from the national health and nutrition examination survey","volume":"11","author":"Simmons","year":"2020","journal-title":"Front Psychiatr"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.sleep.2023.11.033_bib146","series-title":"SILENOR\u00ae (doxepin) tablets, for oral use (revised)","author":"LLC","year":"2020"},{"key":"10.1016\/j.sleep.2023.11.033_bib147","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.smrv.2014.06.001","article-title":"Doxepin for insomnia: a systematic review of randomized placebo-controlled trials","volume":"19","author":"Yeung","year":"2015","journal-title":"Sleep Med Rev"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib148","first-page":"375","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatr Clin"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib149","doi-asserted-by":"crossref","first-page":"77","DOI":"10.64719\/pb.4345","article-title":"Paroxetine-the antidepressant from hell? Probably not, but caution required","volume":"46","author":"Nevels","year":"2016","journal-title":"Psychopharmacol Bull"},{"issue":"10","key":"10.1016\/j.sleep.2023.11.033_bib150","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0269881115599387","article-title":"Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic\/pharmacodynamic comparison with paroxetine in healthy men","volume":"29","author":"Wilson","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib151","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000000311","article-title":"Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause","volume":"22","author":"Pinkerton","year":"2015","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.sleep.2023.11.033_bib152","doi-asserted-by":"crossref","first-page":"989","DOI":"10.5664\/jcsm.5932","article-title":"Use of selective serotonin reuptake inhibitors and sleep quality: a population-based study","volume":"12","author":"Aarts","year":"2016","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib153","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib154","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/104012371202400305","article-title":"The effects of mirtazapine on sleep in patients with major depressive disorder","volume":"24","author":"Dolder","year":"2012","journal-title":"Ann Clin Psychiatr"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib155","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.npp.1300923","article-title":"Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine","volume":"31","author":"Schmid","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.sleep.2023.11.033_bib156","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib157","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2165\/00003495-199753040-00006","article-title":"Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression","volume":"53","author":"Davis","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.sleep.2023.11.033_bib158","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.sleep.2018.01.010","article-title":"Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials","volume":"45","author":"Yi","year":"2018","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/npp.1994.14","article-title":"The effects of nefazodone on sleep architecture in depression","volume":"10","author":"Armitage","year":"1994","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/JCP.0000000000000665","article-title":"Activating and sedating adverse effects of second-generation antipsychotics in the treatment of schizophrenia and major depressive disorder: absolute risk increase and number needed to harm","volume":"37","author":"Citrome","year":"2017","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.sleep.2023.11.033_bib161","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.euroneuro.2014.06.013","article-title":"A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinities","volume":"24","author":"Michl","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2023.11.033_bib162","series-title":"Antipsychotic medications. StatPearls [internet]","author":"Chokhawala","year":"2022"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib163","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-8993(86)90299-4","article-title":"5-Hydroxytryptamine-2 antagonist increases human slow wave sleep","volume":"378","author":"Idzikowski","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.sleep.2023.11.033_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.621691","article-title":"Head-to-Head comparison of sedation and somnolence among 37 antipsychotics in schizophrenia, bipolar disorder, major depression, autism spectrum disorders, delirium, and repurposed in COVID-19, infectious diseases, and oncology from the FAERS, 2004\u20132020","volume":"12","author":"Eugene","year":"2021","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0924-977X(91)90008-I","article-title":"Zuclopenthixol, a combined dopamine D1\/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia","volume":"1","author":"Lublin","year":"1991","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2023.11.033_bib166","series-title":"Informazioni per il paziente CLOPIXOL 10 mg compresse rivestite con film","author":"LI","year":"2021"},{"key":"10.1016\/j.sleep.2023.11.033_bib167","series-title":"Gebrauchsinformation: information f\u00fcr den Anwender Clopixol\u00ae 25 mg","author":"GmbH","year":"2012"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2842","article-title":"Efficacy of tiapride in the treatment of psychiatric disorders: a systematic review","volume":"37","author":"Zangani","year":"2022","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib169","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40267-023-00982-6","article-title":"Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management","volume":"39","author":"Fenton","year":"2023","journal-title":"Drugs Ther Perspect"},{"key":"10.1016\/j.sleep.2023.11.033_bib170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.schres.2023.01.018","article-title":"Meta-analysis of clozapine and insomnia in schizophrenia","volume":"252","author":"Miller","year":"2023","journal-title":"Schizophr Res"},{"key":"10.1016\/j.sleep.2023.11.033_bib171","series-title":"Highlights of prescribing information","author":"Lyrica","year":"2019"},{"key":"10.1016\/j.sleep.2023.11.033_bib172","author":"Agency"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib173","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.smrv.2013.07.005","article-title":"A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions","volume":"18","author":"Roth","year":"2014","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.033_bib174","series-title":"Horizant highlights of prescribing information","author":"Pharmaceuticals","year":"2020"},{"issue":"7","key":"10.1016\/j.sleep.2023.11.033_bib175","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1176\/appi.ajp.2008.08010098","article-title":"Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation","volume":"165","author":"Harvey","year":"2008","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.sleep.2023.11.033_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136772","article-title":"The impact of lithium on circadian rhythms and implications for bipolar disorder pharmacotherapy","volume":"786","author":"Rohr","year":"2022","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib177","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.pra.0000452561.98286.1e","article-title":"Prazosin in the treatment of PTSD","volume":"20","author":"Green","year":"2014","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib178","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/08964280209596396","article-title":"Relationship of sleep hygiene awareness, sleep hygiene practices, and sleep quality in university students","volume":"28","author":"Brown","year":"2002","journal-title":"Behav Med"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib179","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2023.11.033_bib180","series-title":"BELSOMRA\u00ae (suvorexant) tablets highlights of prescribing information","author":"Corp","year":"2020"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib181","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0972-2327.64628","article-title":"Diagnosis and treatment of chronic insomnia","volume":"13","author":"Saddichha","year":"2010","journal-title":"Ann Indian Acad Neurol"},{"issue":"8","key":"10.1016\/j.sleep.2023.11.033_bib182","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.5665\/SLEEP.1172","article-title":"Insomnia subtypes and their relationship to excessive daytime sleepiness in Brazilian community-dwelling older adults","volume":"34","author":"Hara","year":"2011","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib183","first-page":"256","article-title":"Sleep disturbance in bipolar disorder across the lifespan","volume":"16","author":"Harvey","year":"2009","journal-title":"Clin Psychol"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib184","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/sleep\/31.4.481","article-title":"Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?","volume":"31","author":"Pigeon","year":"2008","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib185","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1037\/ccp0000282","article-title":"Treating insomnia in depression: insomnia related factors predict long-term depression trajectories","volume":"86","author":"Bei","year":"2018","journal-title":"J Consult Clin Psychol"},{"issue":"Suppl 17","key":"10.1016\/j.sleep.2023.11.033_bib186","first-page":"28","article-title":"Antidepressant treatment of the depressed patient with insomnia","volume":"60","author":"Thase","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib187","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/S1516-44462011000100017","article-title":"Sedative antidepressants and insomnia","volume":"33","author":"Santos Moraes","year":"2011","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib188","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1389200023338017","article-title":"Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update","volume":"3","author":"Hemeryck","year":"2002","journal-title":"Curr Drug Metabol"},{"issue":"8","key":"10.1016\/j.sleep.2023.11.033_bib189","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bdd.1857","article-title":"Time-dependent inhibition of CYP3A4 by sertraline, a selective serotonin reuptake inhibitor","volume":"34","author":"Masubuchi","year":"2013","journal-title":"Biopharm Drug Dispos"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib190","first-page":"631","article-title":"[Cytochrome P450 3A4 and benzodiazepines]","volume":"105","author":"Otani","year":"2003","journal-title":"Seishin Shinkeigaku Zasshi"},{"issue":"11","key":"10.1016\/j.sleep.2023.11.033_bib191","first-page":"759","article-title":"Pharmacological treatment of insomnia","volume":"40","author":"Lie","year":"2015","journal-title":"P T"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib192","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40261-019-00764-x","article-title":"Effect of CYP3A inhibition and induction on the pharmacokinetics of suvorexant: two phase I, open-label, fixed-sequence trials in healthy subjects","volume":"39","author":"Wrishko","year":"2019","journal-title":"Clin Drug Invest"},{"issue":"10","key":"10.1016\/j.sleep.2023.11.033_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300030","article-title":"CYP3A4 catalyzes the rearrangement of the dual orexin receptor antagonist daridorexant to 4-hydroxypiperidinol metabolites","volume":"18","author":"Treiber","year":"2023","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib194","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/psp4.12606","article-title":"Physiologically-based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors","volume":"10","author":"Ueno","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.sleep.2023.11.033_bib195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2008.06.028","article-title":"Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"114","author":"Gruber","year":"2009","journal-title":"J Affect Disord"},{"issue":"11","key":"10.1016\/j.sleep.2023.11.033_bib196","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11920-022-01369-6","article-title":"Role of melatonin in the management of sleep and circadian disorders in the context of psychiatric illness","volume":"24","author":"Moon","year":"2022","journal-title":"Curr Psychiatr Rep"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib197","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bpsgos.2021.06.004","article-title":"Supersensitivity of patients with bipolar I disorder to light-induced phase delay by narrow bandwidth blue light","volume":"2","author":"Ritter","year":"2022","journal-title":"Biological Psychiatry Global Open Science"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib198","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1037\/a0038655","article-title":"Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial","volume":"83","author":"Harvey","year":"2015","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib199","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1176\/appi.ajp.162.1.50","article-title":"Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems","volume":"162","author":"Harvey","year":"2005","journal-title":"Am J Psychiatr"},{"issue":"2","key":"10.1016\/j.sleep.2023.11.033_bib200","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5664\/jcsm.9646","article-title":"Insomnia and suicide as reported adverse effects of second-generation antipsychotics and mood stabilizers","volume":"18","author":"Miller","year":"2022","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2023.11.033_bib201","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40263-022-00911-7","article-title":"Hypnotic and melatonin\/melatonin-receptor agonist treatment in bipolar disorder: a systematic review and meta-analysis","volume":"36","author":"McGowan","year":"2022","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.sleep.2023.11.033_bib202","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/appi.ajp.2020.177901","article-title":"The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia","volume":"177","author":"Keepers","year":"2020","journal-title":"Am J Psychiatr"},{"issue":"Suppl 2","key":"10.1016\/j.sleep.2023.11.033_bib203","first-page":"8","article-title":"Metabolic changes associated with antipsychotic use","volume":"6","author":"Lieberman","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"10202","key":"10.1016\/j.sleep.2023.11.033_bib204","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2023.11.033_bib205","series-title":"LYBALVI \u2122 (olanzapine and samidorphan) highlights of prescribing information","author":"Alkermes","year":"2021"},{"key":"10.1016\/j.sleep.2023.11.033_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.595584","article-title":"Pharmacotherapy of anxiety disorders: current and emerging treatment options","volume":"11","author":"Garakani","year":"2020","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.sleep.2023.11.033_bib207","series-title":"Generalised anxiety disorder and panic disorder in adults: management","year":"2011"},{"issue":"Suppl 1","key":"10.1016\/j.sleep.2023.11.033_bib208","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatr"},{"key":"10.1016\/j.sleep.2023.11.033_bib209","series-title":"Lyrica, Pregabalin-INN product information","author":"Agency","year":"2021"},{"issue":"1","key":"10.1016\/j.sleep.2023.11.033_bib210","first-page":"32","article-title":"Pharmacotherapy for post-traumatic stress disorder in combat veterans: focus on antidepressants and atypical antipsychotic agents","volume":"37","author":"Alexander","year":"2012","journal-title":"P T"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib211","doi-asserted-by":"crossref","first-page":"365","DOI":"10.30773\/pi.2020.0411","article-title":"Using prazosin to treat posttraumatic stress disorder and associations: a systematic review","volume":"18","author":"Paiva","year":"2021","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.sleep.2023.11.033_bib212","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"680","key":"10.1016\/j.sleep.2023.11.033_bib213","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3399\/bjgp19X701753","article-title":"Prescribing benzodiazepines in general practice","volume":"69","author":"Kennedy","year":"2019","journal-title":"Br J Gen Pract"},{"issue":"5","key":"10.1016\/j.sleep.2023.11.033_bib214","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051788","article-title":"Deprescribing strategies for opioids and benzodiazepines with emphasis on concurrent use: a scoping review","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.sleep.2023.11.033_bib215","series-title":"Hypnotics and benzodiazepines: dependence and withdrawal","author":"Formulary","year":"2013"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib216","first-page":"Cd011481","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","volume":"3","author":"Baandrup","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sleep.2023.11.033_bib217","series-title":"Zolpidem tartrate) hightlights of prescribing information. Bridgewater, NJ","author":"Ambien","year":"2008"},{"key":"10.1016\/j.sleep.2023.11.033_bib218","series-title":"Principles and practice of sleep medicine","article-title":"Chapter 85 - cognitive behavior therapies for insomnia I: approaches and efficacy","author":"Morin","year":"2017"},{"issue":"3","key":"10.1016\/j.sleep.2023.11.033_bib219","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/M14-2841","article-title":"Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis","volume":"163","author":"Trauer","year":"2015","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.sleep.2023.11.033_bib220","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/1559827619867677","article-title":"Cognitive-behavioral therapy for insomnia: an effective and underutilized treatment for insomnia","volume":"13","author":"Rossman","year":"2019","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/j.sleep.2023.11.033_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101597","article-title":"Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: a systematic review and meta-analysis","volume":"62","author":"Hertenstein","year":"2022","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.033_bib222","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.smrv.2018.09.004","article-title":"The effect of non-pharmacological sleep interventions on depression symptoms: a meta-analysis of randomised controlled trials","volume":"43","author":"Gee","year":"2019","journal-title":"Sleep Med Rev"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723004513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723004513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:46:31Z","timestamp":1761407191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945723004513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":221,"alternative-id":["S1389945723004513"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2023.11.033","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2023.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}